For More Information View Related Information

For More Information View Related Information

For More Information View Related Information

Today IntegriChain, a rapidly growing Center City healthcare tech company, made its second healthcare tech acquisition since its strategic partnership with Silicon Valley's Accel-KKR. IntegriChain has acquired Atlanta-based Medical Communication Technologies (MCT). IntegriChain has become a major force in the pharma industry for its unique comprehensive platform (from factory to patient) of data and analytics that help manufacturers improve how patients are able to start and stay on therapy. This is an increasing challenge with new specialty pharmaceuticals, accounting for the major of new product launches.

The acquisition expands IntegriChain's solution offering for payer and government contracting with MCT's software and services for government pricing, a complicating and compliance-heavy operation. With this deal, IntegriChain will now have more than 140 pharma/manufacturer costs on its SaaS platform, including all top-10 and 16 of the top-20.

For More Information View Related Information

IntegriChain is opening a new facility for the rapidly growing team in Ambler, which will focus on BPO services for bio/pharmaceutical manufacturers to help them with their government and commercial rebate processing. More than 40 bio/pharma players rely on this team to process thousands and thousands of claims and keep them in compliance, which is vital to these manufacturers. The press release is here.

IntegriChain has become a major force in the pharma industry for a unique comprehensive platform of data and analytics that help manufacturers improve how patients are able to start and stay on therapy. This is an increasing challenge with new specialty pharmaceuticals, accounting for the major of new product launches. The IntegriChain healthcare tech team is topping well over 100 employees now in Center City and the Ambler team.

For More Information View Related Information

Acquisition Strengthens IntegriChain’s Solutions Addressing Pharma’s Growing Investment in Patient Access

Philadelphia, PA, April 18, 2017 – IntegriChain, a rapidly growing healthcare technology company, today announced the acquisition of PharmaMetrics, a leading provider of contract operations outsourcing and market access analytics software and services. The acquisition strengthens IntegriChain’s ability to deliver industry-leading analytics and contract management solutions to pharmaceutical managed markets teams to support their growing investments in patient access. This is IntegriChain’s first acquisition since entering its strategic partnership with Accel-KKR, a leading technology-focused private equity firm, in 2016.

Use the link to read the full release.

For More Information View Related Information